BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

394 related articles for article (PubMed ID: 11418871)

  • 1. Summary of the Guidelines for Preventing Opportunistic Infections among Hematopoietic Stem Cell Transplant Recipients.
    Dykewicz CA; ; ;
    Clin Infect Dis; 2001 Jul; 33(2):139-44. PubMed ID: 11418871
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytomegalovirus prophylaxis and treatment after hematopoietic stem cell transplantation in Canada: a description of current practices and comparison with Centers for Disease Control/Infectious Diseases Society of America/American Society for Blood and Marrow Transplantation guideline recommendations.
    Fraser GA; Walker II;
    Biol Blood Marrow Transplant; 2004 May; 10(5):287-97. PubMed ID: 15111928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Antiviral prophylaxis].
    Graubner UB
    Klin Padiatr; 2001 Sep; 213 Suppl 1():A69-76. PubMed ID: 11577365
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Guidelines for preventing opportunistic infections among hematopoietic stem cell transplant recipients.
    ; ;
    MMWR Recomm Rep; 2000 Oct; 49(RR-10):1-125, CE1-7. PubMed ID: 11718124
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Guidelines for preventing opportunistic infections among hematopoietic stem cell transplant recipients.
    ; ;
    Biol Blood Marrow Transplant; 2000; 6(6a):7-83. PubMed ID: 11185897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New guidelines are a comprehensive resource for managing infection risk among hematopoietic stem cell transplant patients.
    Rollins G
    Rep Med Guidel Outcomes Res; 2000 Nov; 11(23):1-2, 5. PubMed ID: 11899981
    [No Abstract]   [Full Text] [Related]  

  • 7. Vaccination of stem cell transplant recipients: recommendations of the Infectious Diseases Working Party of the EBMT.
    Ljungman P; Engelhard D; de la Cámara R; Einsele H; Locasciulli A; Martino R; Ribaud P; Ward K; Cordonnier C;
    Bone Marrow Transplant; 2005 Apr; 35(8):737-46. PubMed ID: 15750612
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preventing opportunistic infections in bone marrow transplant recipients.
    Dykewicz CA
    Transpl Infect Dis; 1999 Mar; 1(1):40-9. PubMed ID: 11428970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preventing opportunistic infections after hematopoietic stem cell transplantation: the Centers for Disease Control and Prevention, Infectious Diseases Society of America, and American Society for Blood and Marrow Transplantation Practice Guidelines and beyond.
    Sullivan KM; Dykewicz CA; Longworth DL; Boeckh M; Baden LR; Rubin RH; Sepkowitz KA; ; ;
    Hematology Am Soc Hematol Educ Program; 2001; ():392-421. PubMed ID: 11722995
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation: joint recommendations of the European Group for Blood and Marrow Transplantation, the Center for International Blood and Marrow Transplant Research, and the American Society of Blood and Marrow Transplantation.
    Rizzo JD; Wingard JR; Tichelli A; Lee SJ; Van Lint MT; Burns LJ; Davies SM; Ferrara JL; Socié G
    Biol Blood Marrow Transplant; 2006 Feb; 12(2):138-51. PubMed ID: 16443512
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibiotic prophylaxis in patients receiving hematopoietic stem cell transplant.
    Sepkowitz KA
    Bone Marrow Transplant; 2002 Mar; 29(5):367-71. PubMed ID: 11919724
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An international comparison of current strategies to prevent herpesvirus and fungal infections in hematopoietic cell transplant recipients.
    Pollack M; Heugel J; Xie H; Leisenring W; Storek J; Young JA; Kukreja M; Gress R; Tomblyn M; Boeckh M
    Biol Blood Marrow Transplant; 2011 May; 17(5):664-73. PubMed ID: 20699126
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ex vivo expansion and prophylactic infusion of CMV-pp65 peptide-specific cytotoxic T-lymphocytes following allogeneic hematopoietic stem cell transplantation.
    Micklethwaite K; Hansen A; Foster A; Snape E; Antonenas V; Sartor M; Shaw P; Bradstock K; Gottlieb D
    Biol Blood Marrow Transplant; 2007 Jun; 13(6):707-14. PubMed ID: 17531781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinically-based determination of safe DNAemia cutoff levels for preemptive therapy or human cytomegalovirus infections in solid organ and hematopoietic stem cell transplant recipients.
    Lilleri D; Baldanti F; Gatti M; Rovida F; Dossena L; De Grazia S; Torsellini M; Gerna G
    J Med Virol; 2004 Jul; 73(3):412-8. PubMed ID: 15170637
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 1997 USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus: disease-specific recommendations. USPHS/IDSA Prevention of Opportunistic Infections Working Group. US Public Health Services/Infectious Diseases Society of America.
    Clin Infect Dis; 1997 Oct; 25 Suppl 3():S313-35. PubMed ID: 9356832
    [No Abstract]   [Full Text] [Related]  

  • 16. Guidelines for preventing infectious complications among hematopoietic cell transplant recipients: a global perspective. Preface.
    Tomblyn M; Chiller T; Einsele H; Gress R; Sepkowitz K; Storek J; Wingard JR; Young JA; Boeckh MJ
    Bone Marrow Transplant; 2009 Oct; 44(8):453-5. PubMed ID: 19861977
    [No Abstract]   [Full Text] [Related]  

  • 17. Early infections in adults undergoing matched related and matched unrelated/mismatched donor stem cell transplantation: a comparison of incidence.
    van Kraaij MG; Verdonck LF; Rozenberg-Arska M; Dekker AW
    Bone Marrow Transplant; 2002 Sep; 30(5):303-9. PubMed ID: 12209352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Guidelines for preventing opportunistic infections among HIV-infected persons--2002. Recommendations of the U.S. Public Health Service and the Infectious Diseases Society of America.
    Kaplan JE; Masur H; Holmes KK; ;
    MMWR Recomm Rep; 2002 Jun; 51(RR-8):1-52. PubMed ID: 12081007
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of infection caused by Pneumocystis carinii in transplant recipients.
    Fishman JA
    Clin Infect Dis; 2001 Oct; 33(8):1397-405. PubMed ID: 11565082
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 1999 USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus. U.S. Public Health Service (USPHS) and Infectious Diseases Society of America (IDSA).
    Infect Dis Obstet Gynecol; 2000; 8(1):5-74. PubMed ID: 10741830
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 20.